Shared on30 Jul 25Fair value Increased 23%
The consensus analyst price target for Laurus Labs has been raised from ₹564.31 to ₹698.46, primarily reflecting stronger profitability as evidenced by a significant increase in net profit margin and a lower future P/E ratio, indicating improved earnings outlook and valuation. What's in the News Board meeting scheduled to consider and approve un-audited financial results for the quarter ended June 30, 2025.
Shared on01 May 25Fair value Increased 0.78%
AnalystConsensusTarget has decreased revenue growth from 16.8% to 13.6%, decreased profit margin from 14.1% to 11.0% and increased future PE multiple from 34.3x to 48.4x.
Shared on23 Apr 25Fair value Increased 2.35%
AnalystConsensusTarget has decreased shares outstanding growth rate from 0.0% to -0.0%.
Shared on17 Apr 25Fair value Decreased 1.22%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 5.42%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 9.06%
AnalystConsensusTarget has increased future PE multiple from 30.2x to 34.2x.